Competition & Markets Authority
CMA opens investigation into NHS hospital trusts merger
The CMA yesterday started an investigation into the proposed merger between NHS hospital trusts in Poole and Bournemouth.
In 2013, the Competition and Markets Authority’s (CMA) predecessor, the Competition Commission, prohibited a previous merger between the Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust and Poole Hospital NHS Foundation Trust. As a result, the hospital trusts were required to enter into a 10-year commitment not to merge without the prior approval of the CMA.
Since the Competition Commission’s decision, there have been significant changes to policy within the NHS that have affected the role that competition plays. Competition between NHS hospitals is no longer used by the NHS to drive quality, with collaboration often viewed as a better way to meet increasing demands for care and deliver better value.
This has been taken into account in recent hospital mergers reviewed by the CMA, including the merger between Aintree University Hospital NHS Foundation Trust and The Royal Liverpool and Broadgreen University Hospitals NHS Trust, which was cleared in August 2019.
The CMA’s assessment of the potential effects of this merger on NHS services in the east Dorset area will take these policy changes into account. During the investigation, the CMA will work closely with Bournemouth and Poole Hospital trusts, the NHS regulators and local commissioners to assess the role that competition plays in how the hospitals provide services and whether any loss of competition brought about by the merger could have a negative impact on patients.
The CMA is also inviting views on these issues from patients and their representative groups, commissioning groups, other healthcare providers, regulators, local authorities and other interested bodies.
More broadly, the CMA is aware of longer-term NHS plans to exempt mergers between NHS hospitals from CMA review, which it fully supports.
For more information, visit the CMA’s dedicated webpage for the Royal Bournemouth and Christchurch Hospitals / Poole Hospital NHS Foundation Trusts merger investigation.
For media enquiries, contact the CMA press team on 020 3738 6460 or firstname.lastname@example.org.
Latest News from
Competition & Markets Authority
CMA levies fines of £2.3m and secures £8m for NHS in pharma probe10/07/2020 09:20:00
The CMA has formally concluded that 3 pharmaceutical companies took part in an illegal arrangement in relation to the supply of life-saving medicine.
Korg fined £1.5 million for illegally preventing online price discounts09/07/2020 14:20:00
Lessons from the CMA’s investigation into Korg's use of illegal resale price maintenance (RPM).
CMA orders insurance provider to fix PPI breaches08/07/2020 15:10:00
The CMA has taken action against Cardif Pinnacle, and written to Nationwide and Lloyds, after they failed to provide accurate annual PPI reminders.
Trading systems merger raises competition concerns08/07/2020 12:20:00
The CMA has found that ION’s completed purchase of Broadway Technology raises competition concerns in the supply of electronic trading systems.
CMA secures loan write-off from payday lender07/07/2020 13:48:00
Following CMA action, payday lender Shelby Finance has written off loans and apologised to customers after not providing them with important information.
Court orders disqualification of estate agent cartel director06/07/2020 10:05:00
In the first contested case of its kind, the CMA has secured the disqualification of a director whose Somerset estate agency breached competition law.
COVID-19: CMA secures refunds from second major holiday lets firm03/07/2020 13:20:00
Following an investigation by the CMA, Sykes Cottages has reversed its policy on cancelled bookings and will now offer customers full refunds.
Latest update from CMA COVID-19 taskforce03/07/2020 12:20:00
The CMA has published a third update from its COVID-19 taskforce, which monitors and responds to competition and consumer problems arising from the pandemic.